AZD-2184

N/A

Report date: 2025/12/01 17:16:42

NME

Base Information

Drug NameAZD-2184

Drug Alias NameAZD-218411CAZD-2184

ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11C +[5]

Mechanisms of ActionPositron-emission tomography enhancersAmyloid binders

TargetsAmyloid

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A